Learn more

LIFEGROUP SPA

Overview
  • Total Patents
    63
About

LIFEGROUP SPA has a total of 63 patent applications. Its first patent ever was published in 1991. It filed its patents most often in Italy, Canada and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and macromolecular chemistry and polymers are BRIDGE PHARMA INC, SCHAPER & BRUEMMER GMBH and BAJER SHERING FARMA AKTSIENGEZ.

Patent filings per year

Chart showing LIFEGROUP SPAs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Della Valle Francesco 55
#2 Lorenzi Silvana 52
#3 Marcolongo Gabriele 38
#4 Leon Alberta 22
#5 Della Valle Federica 12
#6 Cerini Roberto 11
#7 Calderini Gabriella 7
#8 Valle Francesco Della 5
#9 Samson Jacobus C J J 4
#10 Galzigna Lauro 4

Latest patents

Publication Filing date Title
US5814650A Biotin amides able to control glucidic metabolisms under dysmetabolic conditions and relative therapeutical compositions
WO9618391A2 Use of mono and bicarboxylic acid amides for the manufacture of a medicament active at the peripheral cannabinoid receptor
EP0799188A2 Amides of mono and dicarboxylic acids with glycosamines, selectively active on the cannabinoid peripheral receptor
AU3254495A Highly bioadhesive and mucoadhesive compositions for the treatmenof epithelia and mucous membranes
AU2110095A Glucosidic derivatives of n-acyl alkylamines exerting neuroprotective, neurotrophic and anti-inflammatory action, useful in acute and chronic disorders of the central nervous system connected with excitotoxicity
CA2186245A1 Glucosidic derivatives of n-acyl alkylamines exerting neuroprotective, neurotrophic and anti-inflammatory action, useful in acute and chronic disorders of the central nervous system connected with excitotoxicity
US5925678A Use of N-acyl derivatives of aminoalcohols in the manufacture of a medicament for practicing neuroprotective action in neuropathological states connected with excitotoxicity
CA2186243A1 Use of n-acyl derivatives of aminoalcohols in the manufacture of a medicament for practising neuroprotective action in neuropathological states connected with excitotoxicity
US5679667A Aminoalcohols-N-Acyl derivatives as therapeutical agents against the neurogenic endoneural edema of the peripheral nerve
US5618842A N-acyl derivatives of aminoalcohols with polycarboxylic acids able to modulate mast cells in inflammatory processes having neuroimmunogenic origin
CA2121952A1 Topical preparations for the treatment of acne and acneiform dermatitis
US5696099A Topical preparations for the treatment of acne and acneiform dermatitis
US5480645A Hydroxyamines N-acyl derivatives having scavenger activity and useful in acute and chronic pathologies associated with peroxidation and inflammation phenomena
EP0599188A1 Trans and CIS traumatic acid salts having cicatrizant activity associated to bacteriostatic, antiviral, antibiotic or antifungal activity
US5506224A N-acyl derivatives of aminoalcohols active as local autacoids and useful in the therapy of autoimmune processes
EP0590563A1 Biotin amides, a process for their preparation and therapeutical compositions containing them as the active principles for the treatment of diabetes and relative complicating diseases
CA2094548A1 Aminoalcohols-n-acylderivatives as therapeutical agents against the neurogenic endoneural oedema developing at the peripheral nerve
EP0550006A2 Use of N-acyl derivatives of aminoalcohols for the manufacture of a medicament for the treatment of pathologies involving mast cells
EP0550008A2 Use of n-acyl derivatives of aminoalcohols with polycarboxylic acids for the manufacture of a medicament for the treatment of pathologies relating to mast cells
EP0553456A1 Water soluble derivatives of biotin and related therapeutical compositions